Literature DB >> 8844482

Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.

H Tada1, S Saitoh, Y Nakagawa, H Hirana, M Morimoto, T Shima, K Shimamoto, T Okanoue, K Kashima.   

Abstract

Between 1991 and 1994, at Hoshigaoka Koseinenkin Hospital, we treated 280 patients with chronic hepatitis C with interferon (IFN), and ischemic colitis occurred in two patients (0.7%) during the treatment. Melena appeared in case 1 in the 2nd month after the initiation of IFN-alpha treatment, and in case 2 in the 6th month. In both patients, longitudinal ulcerations in the descending colon were revealed by urgent colonoscopy, and these resolved within 2 weeks after discontinuation of the IFN treatment. It appears that ischemic colitis was associated with the IFN treatment, suggesting that attention should be paid to this possible complication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844482     DOI: 10.1007/bf02355061

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  13 in total

1.  Reversible vascular occlusion of the colon.

Authors:  S J BOLEY; S SCHWARTZ; J LASH; V STERNHILL
Journal:  Surg Gynecol Obstet       Date:  1963-01

2.  Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

Authors:  L E Rönnblom; G V Alm; K E Oberg
Journal:  Ann Intern Med       Date:  1991-08-01       Impact factor: 25.391

3.  Gastrointestinal complications of collagen vascular diseases. Surgical implications.

Authors:  N M Matolo; D Albo
Journal:  Am J Surg       Date:  1971-11       Impact factor: 2.565

4.  Ischaemic colitis.

Authors:  A Marston; M T Pheils; M L Thomas; B C Morson
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

5.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; L Murray; J Waggoner; Z Goodman; S M Banks; J H Hoofnagle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C.

Authors:  A Mitoro; M Yoshikawa; K Yamamoto; M Mimura; Y Yoshikawa; A Shiroi; T Mochi; T Sakamoto; J Yamao; E Kikuchi
Journal:  Intern Med       Date:  1993-04       Impact factor: 1.271

7.  [Ulcerative colitis in hairy cell leukemia. A case report].

Authors:  P Pecorari
Journal:  Recenti Prog Med       Date:  1991-05

8.  Gangrenous ischemic colitis of the rectum: a rare complication of systemic lupus erythematosus.

Authors:  P Reissman; E G Weiss; T A Teoh; F V Lucas; S D Wexner
Journal:  Am J Gastroenterol       Date:  1994-12       Impact factor: 10.864

9.  Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha.

Authors:  J A Sparano; J P Dutcher; R Kaleya; G Caliendo; J Fiorito; S Mitsudo; R Shechner; S J Boley; R Gucalp; N Ciobanu
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860

10.  Diffuse ischemic colitis associated with systemic lupus erythematosus--response to subtotal colectomy.

Authors:  M G Kistin; M M Kaplan; J T Harrington
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

View more
  8 in total

1.  Ischemic colitis: clinical presentation, localization in relation to risk factors, and long-term results.

Authors:  Philippe M Glauser; Petra Wermuth; Gieri Cathomas; Evelyn Kuhnt; Samuel A Käser; Christoph A Maurer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

2.  Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Authors:  Yvette Leung; Stefan J Urbanski; Lynn Schindel; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 3.  Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.

Authors:  Mark S Sulkowski; Curtis Cooper; Bela Hunyady; Jidong Jia; Pavel Ogurtsov; Markus Peck-Radosavljevic; Mitchell L Shiffman; Cihan Yurdaydin; Olav Dalgard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-08       Impact factor: 46.802

Review 4.  Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report.

Authors:  Su Jung Baik; Tae Hun Kim; Kwon Yoo; Il Hwan Moon; Min-Sun Cho
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

Review 5.  Thrombosis Associated with Viral Hepatitis.

Authors:  Luca Galli; Victor E A Gerdes; Luigina Guasti; Alessandro Squizzato
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

Review 6.  Treatment of hepatitis C virus infection and associated vascular complications: a literature review.

Authors:  Reza Karbasi-Afshar
Journal:  Iran J Med Sci       Date:  2014-05

7.  Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa.

Authors:  Anne Jarry; Florent Malard; Chantal Bou-Hanna; Guillaume Meurette; Mohamad Mohty; Jean-François Mosnier; Christian L Laboisse; Céline Bossard
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-09-20

Review 8.  Type I interferons for induction of remission in ulcerative colitis.

Authors:  Yongjun Wang; John K MacDonald; Eric I Benchimol; Anne Marie Griffiths; A Hillary Steinhart; Remo Panaccione; Cynthia H Seow
Journal:  Cochrane Database Syst Rev       Date:  2015-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.